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ABSTRACT
Regulation of alternative splicing is controlled by
pre-mRNA sequences (cis-elements) and trans-
acting protein factors that bind them. The combina-
torial interactions of multiple protein factors with
the cis-elements surrounding a given alternative
splicing event lead to an integrated splicing deci-
sion. The mechanism of multifactorial splicing
regulation is poorly understood. Using a splicing-
sensitive DNA microarray, we assayed 352
Caenorhabditis elegans alternative cassette exons
for changes in embryonic splicing patterns
between wild-type and 12 different strains carrying
mutations in a splicing factor. We identified many
alternative splicing events that are regulated by
multiple splicing factors. Many splicing factors
have the ability to behave as splicing repressors
for some alternative cassette exons and as
splicing activators for others. Unexpectedly, we
found that the ability of a given alternative splicing
factor to behave as an enhancer or repressor of a
specific splicing event can change during develop-
ment. Our observations that splicing factors
can change their effects on a substrate during de-
velopment support a model in which combinatorial
effects of multiple factors, both constitutive and
developmentally regulated ones, contribute to the
overall splicing decision.
INTRODUCTION
Alternative splicing is a common mechanism for the gen-
eration of alternative isoforms of transcripts and proteins.
This process can be regulated in tissue-speciﬁc or develop-
mental stage-speciﬁc manners, and can be responsive
to signaling cues. The regulation of alternative splicing is
achieved through the interplay between sequence elements
of the pre-mRNA, known as cis-elements, and trans-
acting splicing factor proteins that bind to them.
Multiple splicing factor proteins that act to repress or
activate splicing have been identiﬁed. Many of these
splicing factors can be grouped into families, and different
families can have antagonistic effects on alternative
splicing decisions. Two main families of splicing factors
have been described with detail: the SR (serine/arginine)
and the hnRNPs proteins (heterogeneous nuclear ribo-
nucleoparticles) (1,2). SR proteins are generally described
as splicing enhancers but they are also known to negative-
ly regulate splicing in particular cases (3). Comparatively,
proteins of the hnRNP family are generally described as
negative regulators of splicing, but opposite effects have
also been reported (4). Identiﬁcation of alternative splicing
factors and the sequences that they interact with has led
to a model of a splicing code. A goal of research in the
ﬁeld is to solve this code so that knowledge of the regula-
tory elements on a pre-mRNA and their relative location,
combined with knowledge of the array of splicing factors
present in the nucleus, will allow for the ability to predict
the outcome of alternative splicing (5–7).
Detailed biochemical studies of several alternatively
spliced genes have shown that splicing regulation can
occur through multiple distinct pre-mRNA splicing
factors interacting with multiple distinct cis-elements.
Many of these factors are ubiquitously expressed, but
in combination with tissue-speciﬁc factors, splicing
speciﬁcity can be achieved. The combinatorial control of
alternative splicing by various cis-elements on speciﬁc
events has been described earlier (6). A detailed analysis
of the RNA features that control alternative splicing was
recently published; this work takes into account many
features in pre-mRNA sequences and is able to make
successful predictions for how alternatively spliced
regions are regulated in different tissues (8). However,
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protein factors regulate the actual assembly of an active
spliceosome are poorly understood.
Combinatorial regulation of a speciﬁc splicing event by
the binding of multiple splicing factors to cis-elements has
been demonstrated for many genes. For example PTB
and hnRNP A1/A2 were recently described as common
regulators of PKM alternative splicing (9,10). hnRNP H
and hnRNP A1 can collaborate to regulate 50-splice site
selection (11). Detailed study of the neural-speciﬁc alter-
native cassette exon of the c-src gene has identiﬁed
polypyrimidine tract binding protein (PTB), its neural
speciﬁc homolog nPTB, hnRNP H, Fox2 and other
factors as participating in this tissue-speciﬁc splicing regu-
lation (12). In a careful study to identify alternative
splicing events regulated by different members of the
hnRNP family of factors, RNA interference was per-
formed on 14 different hnRNPs. Analysis of splicing
by reverse transcription–polymerase chain reaction (RT–
PCR) on 56 different alternative splicing events indicated
that all of the splicing factors had a regulatory role for at
least one of the events. Some hnRNPs, like hnRNP K, act
like global regulators having effects on many alternative
splicing events (>40%), while others, such as hnRNP M,
are highly speciﬁc regulators affecting <2% of the alter-
native splicing events studied (13). A recent study of the
binding afﬁnities of four genes of the hnRNP A/B family
shows that they have a combinatorial network of inter-
actions, where they might regulate similar populations of
mRNAs (14). A recent report also shows that hnRNP L
can act as a splicing enhancer and silencer (15). In many
aspects, alternative splicing decisions are analogous to
transcriptional initiation; multiple factors, both positive
and negative, assemble onto a nucleic acid control
region, and the combination of assembled factors leads
to an integrated decision (which isoform to generate by
splicing or whether to initiate transcription). In order to
understand splicing regulation on a global level, it will be
key to uncover the interactions of multiple splicing factors
with any given pre-mRNA and to reveal how these inter-
actions lead to splicing decisions.
Most of the studies of alternative splicing regulation
that uncovered multiple interacting splicing factors were
performed using ex vivo systems. The Caenorhabditis
elegans model system provides an excellent platform
from which to probe the combinatorial interactions of al-
ternative splicing factors on target genes in animals.
Regulated alternative splicing occurs in this species, and
homologs of all the major vertebrate alternative splicing
factors are present in the genome (16). The use of two-
color alternative splicing reporter transgenes to study
splicing regulation has indicated that multiple factors in
the same or different families play a role in the regulation
of alternative splicing in a tissue-speciﬁc and developmen-
tal manner in these worms (17–19). Genetic analysis of the
regulation of the alternative splicing of the C. elegans
unc-52 gene has uncovered four different splicing factor
genes, mec-8, smu-1, smu-2 and sym-2, which play a role in
this splicing regulation (20–22).
In our lab, we have developed a DNA microarray that
can measure changes in alternative splicing in 352
alternative cassette exons. We have previously used this
platform to measure changes in splicing during
C. elegans development and speciation, and we have
used it to uncover evidence of alternative splicing
coupled to developmentally-regulated non-sense-mediated
decay (23–25). In this report, we use the splicing-sensitive
DNA microarrays to analyze the differences between
mRNA isolated from wild-type worms and 13 different
C. elegans strains carrying viable genetic defects in alter-
native splicing factors. Our analysis uncovers many
examples of coordinated regulation of alternative
splicing. Examples of splicing factors that are functionally
redundant, as well as splicing factors that appear to work
antagonistically, are also revealed. In addition, we identify
examples in which one splicing factor functions as a sup-
pressor of an alternative splicing event at one stage of
development and as an enhancer of the same alternative
splicing event at a separate stage, indicating the import-
ance of the combinatorial effect of multiple factors on
splicing.
MATERIALS AND METHODS
Strains and RNA samples
Splicing factors mutant strains: KH1125 [asd-1(yb978)]
(17), VC176 [exc-7(ok370)], CB398 [mec-8(e398)] (26),
VC463 [rsp-2(ok639)], RB1451 [rsp-5(ok324)], SP2230
[sym-2(mn617)] (20), CB5380 [fox-1(e2643)] (27),
VC119 [ptb-1(gk113)], VC659 [hrp-1(ok963)], CB950
[unc-75(e950)] (28) and RW2306 [sup-12(st89)] (29)
were obtained from the Caenorhabditis Genetics Center
(CGC). Strains RB1451, VC119, VC176, VC659 and
VC463 were generated by the C. elegans Reverse
Genetics Core Facility at UBC, which is part of the
International C. elegans Gene Knockout Consortium.
Strains TM3406 [hrpf-1(tm3406)] and TM367
[rsp-6(tm367)], were generated and obtained from the
National BioResource Project-C. elegans, Japan. The
tm3406;mn617 double mutant strain was generated by
conventional genetic crosses. F2 worms were screened
using PCR analysis for those that were homozygous for
both mutants. Worm samples: large quantities of
mixed-stage worms were grown on egg–NGM plates
with HB101 until plates were conﬂuent; at that point
worms were synchronized using 1% sodium hypochlorite
and 0.5M NaOH to isolate embryos. Embryo samples
were taken after axenization of adults from mixed-stage
cultures. Larval and adult stages were synchronized from
embryos that we let hatch overnight in M9 buffer at room
temperature. The next morning synchronized L1s were
washed in fresh M9 and plated onto egg–NGM plates
with HB101, and collected at the fourth larval stage.
Total RNA samples were extracted with Trizol reagent
(Invitrogen). mRNA was puriﬁed from total RNA using
the PolyA Tract mRNA isolation system (Promega).
Splicing-sensitive microarrays and data analysis
We previously reported a DNA microarray capable of
detecting changes in the isoform ratios (IR) for 352 alter-
native cassette exons in C. elegans (25). cDNA derived
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labeled with Alexa Fluor dyes (555 and 647) using the
SuperScript Indirect Labeling System (Invitrogen) for
each of the strains used. Hybridizations were done in du-
plicate with dye swaps. Data were normalized, further
processed and isoform ratios (IR) were calculated as
described earlier (25). In brief, a positive IR ratio equals
more inclusion of the cassette exon in the reference sample
(N2) while a negative IR ratio means more inclusion in the
experimental sample (splicing factor mutant).
Semiquantitative and quantitative RT–PCR
RT–PCR was performed using SuperScriptIII One-Step
RT–PCR Kit (Invitrogen). An amount of 25ng of
mRNA from a sample representing a biological replica
of the sample used for the microarray analysis were used
in each reaction, and the number of PCR cycles was 27–30
depending on the speciﬁc mRNA targeted. Primer se-
quences are available upon request. PCR products were
ﬁrst analyzed using ethidium bromide-stained agarose gels
and later quantiﬁed using an Agilent Bioanalyzer 2100
with the Agilent DNA 1000 kit (Agilent). AS ratios and
inclusion proportions were calculated from the molar con-
centrations of each isoform as reported by the Bioanalyzer
2100 software (Agilent). For expression analysis of mec-8,
sup-12, asd-1, rsp-2 and rsp-5 quantitative RT–PCR was
performed for 45 cycles using Lightcycler DNA Master
SYBRgreen I (Roche Applied Science, Pensberg,
Germany) in 384-well plates using Lightcycler 480
(Roche), individual PCR ampliﬁcations were carried out
in triplicates and two biological replicas were used to cal-
culate average and standard deviations. The log2 ratios
were calculated as described earlier (30), by using gpd-2
and rps-1 as reference housekeeping genes to normalize
between samples. The log2 ratios represent the changes
between embryos and adults, with negative values repre-
senting a downregulation of expression in adults
compared to the embryo sample.
RESULTS
In order to analyze the global effects on alternative
splicing for different alternative splicing factors, we
employed splicing-sensitive microarrays that monitor the
isoform ratios for 352 events of alternative splicing in
C. elegans (25). Thirteen different strains carrying muta-
tions in 12 alternative splicing factors and one
double-mutant strain were used in this study (Table 1).
These represent mutant alleles of homologs of a range of
known mammalian splicing factors. These include
members of the hnRNP F/H family (sym-2, hrpf-1), the
SR protein family (rsp-2, rsp-5, rsp-6), hnRNP A1 (hrp-1),
the Fox1/2 family (fox-1, asd-1), a muscle-speciﬁc factor
(sup-12), a neural-speciﬁc ELAV homolog (exc-7), a regu-
lator of splicing whose loss leads to mechanosensory
defects (mec-8) and a homolog of PTB (ptb-1). Eight of
these mutants correspond to genomic deletions that
remove several exons of each splicing factor (it is
assumed that many are null alleles but we have no add-
itional data as to whether these are complete or partial
loss-of-function); mec-8(e398) is an amber mutation; the
asd-1, sup-12 and sym-2 alleles used here are missense
mutations that were previously characterized as null
alleles (17,22,31). Messenger RNA was isolated from
synchronized embryos for each of the mutant strains
and compared against wild-type Bristol N2 embryonic
mRNA on the microarrays, with replicates used in
dye-swap experiments. The number of alternative
splicing events for each strain that show >2-fold changes
in isoform ratios (IR) are indicated in Table 1 [See
‘Materials and Methods’ section and (23) for details in
how IR was calculated].
In total, we found that 134/352 (38%) events of
alternative splicing measured by our microarray have at
least a 2-fold change in isoform ratio in at least one
mutant strain. The strain harboring a mutant allele of
the splicing factor fox-1 shows the greatest number of
splicing events with >2-fold changes, while a strain
carrying a mutant allele of the neuro-speciﬁc exc-7 gene
Table 1. Alternative splicing ratio changes in mutant strains
Mutant Genes with isoform Human homolog Mutation References
Ratio changes >2-fold
asd-1(yb978) 3 FOX1/2 Missense mutation G140R (17)
exc-7(ok370) 0 ELAV 4 1404-bp deletion C. elegans Gene Knockout consortium
fox-1(e2643) 30 FOX1/2 1255-bp deletion (27)
hrp-1(ok963) 11 hnRNP A1 843-bp deletion C. elegans Gene Knockout consortium
hrpf-1(tm3406) 1 hnRNP F/H 426-bp deletion National BioResource Project, C. elegans
mec-8(e398) 17 RBPMS2 Amber mutation Q177X (39)
ptb-1(gk113) 8 PTB 542-bp deletion C. elegans Gene Knockout consortium
rsp-2(ok639) 10 SRSF4 (SRp75) 984-bp deletion C. elegans Gene Knockout consortium
rsp-5(ok324) 13 SRSF2 (SC35) 1116-bp deletion C. elegans Gene Knockout consortium
rsp-6(tm367) 12 SRSF3 (SRp20) 395-bp deletion National BioResource Project, C. elegans
sup-12(st89) 20 RBM24 Missense mutation within RRM, G77E (31)
sym-2(mn617) 3 hnRNP F/H Missense mutation Y163N (40)
unc-75(e950) 0 CUG-BP 6900-bp deletion (33)
hrpf-1; sym-2 17 hnRNP F/H 843-bp deletion and missense mutation This work
Microarray analysis of embryonic mRNA between indicated splicing factor mutant strains and N2. The number of genes on the microarray
undergoing >2-fold changes in isoform ratios in the mutant strain are indicated. Human homologs of the genes are indicated, as well as the
type of mutation in the C. elegans genome.
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threshold (Table 1). Supplementary Table S1 shows the
isoform ratios of each gene tested on the microarray for
each of the mutant strains. In order to ascertain whether
there are splicing factors that have similar functions in this
analysis, we performed a hierarchical clustering of the
results for the 12 single splicing factor mutant strains for
all the 352 genes on the microarray (Figure 1). One inter-
esting result is that splicing factors belonging to different
families cluster together (for example the SR protein rsp-5
with the Fox1/2 protein fox-1), suggesting that they are
involved in the co-regulation of particular splicing events
and that both are required for proper control. It is import-
ant to note that the mutation to hrp-1 is unique in this
group in that homozygous mutants have very severe
phenotypes and developmental delays (C. elegans Gene
Knockout Consortium). As such, the strain used to
grow the hrp-1 mutant contains a balancer, so that the
embryos tested were a mixture of worms homozygous
and heterozygous for the hrp-1 mutation. Therefore, the
11 alternative splicing events showing changes above the
threshold in the hrp-1 mutant worms in Table 1 represent
a minimum estimate of targets for hrp-1 alternative
splicing regulation.
Several examples of redundancy in the regulation of
splicing by members of the same family of factors have
been reported earlier [for examples in C. elegans see
(18,32)]. In our analysis in Figure 1 we noted that some
members of the same family, such as fox-1 and asd-1,
clustered fairly closely, indicating that they have coopera-
tive or partially overlapping functions on similar sub-
strates. In another interesting case we saw that pairs of
proteins from the same family, the hnRNP F/H genes
sym-2 and hrpf-1, were fairly distant in the clustering
analysis. This could indicate that they function on a
small number of distinct substrates, or that they have
redundant function so that the majority of hnRNP
F/H-dependent splicing events are unaffected by the loss
of one family member. In order to test this, we generated
an hrpf-1;sym-2 double mutant strain and observed that it
was viable without any obvious phenotypic defects,
similar to either allele on its own. hrpf-1 and sym-2 repre-
sent two of the three hnRNP F/H splicing factors genes
present in the worm genome, the third family member is
hrpf-2 for which no mutant allele is available. Our array
analysis indicates that the double-mutant strain has many
more changes in splicing isoform ratio at the >2-fold level
when compared to either mutant alone (17 changes
>2-fold for the double-mutant compared to three for the
sym-2 mutant and one for the hrpf-1 mutant) (Table 1).
This indicates that there are extensive alternative splicing
substrates for which these two splicing factors have
redundant function, and that a small number of the sub-
strates are uniquely regulated by each. The use of the
double-mutant strain for these two family members
allows for the discovery of more hnRNP F/H-dependent
alternative splicing events.
After examining the microarray data across the mutant
strains, we were able to uncover examples of individual
alternative splicing events that are regulated by multiple
splicing factors. To aid in this analysis, we created a term
called the co-regulation value; it is the sum for each gene
of the positive value for all splicing isoform ratios relative
to N2 from each of the mutant strains. The top 18
coordinately regulated genes that have at least one
isoform ratio in one mutant change >1.5 log2 are shown
in Table 2. In order to further analyze these results, we
conﬁrmed by RT–PCR the alternative splicing in
wild-type and mutant strains for events with high
co-regulation values for RNA samples representing bio-
logical replicates of the ones used for the microarray ex-
periments. Figure 2 shows the RT–PCRs for F42G9.6,
pqn-52, C06A6.4, lec-3 and hrpf-1. For these splicing
events we performed RT–PCRs for all twelve splicing
factors mutants and found a validation for the microarray
Table 2. Genes showing highest co-regulation in multiple mutant
strains tested on the microarray
Gene Coregulation
value
F42G9.6 10.75
hrpf-1 7.95
gcy-31 7.05
K04H4.2 8.72
lec-3 9.42
egl-3 8.03
rnp-6 6.03
phy-2 6.11
F11E6.1 6.31
C06A6.4 6.37
C06G8.3 6.53
H14E04.2 6.07
mbk-2 5.62
ZC518.1 6.21
rme-8 5.03
pqn-52 4.82
gsy-1 3.81
tnt-3 3.59
The co-regulation value is the sum of the positive values of the isoform
ratios (log2) for each gene over all mutant strains tested.
rsp-6
sym-2
sup-12
mec-8
exc-7
ptb-1
rsp-2
fox-1
rsp-5
asd-1
hrp-1
hrpf-1
Figure 1. Hierarchical clustering of splicing factors mutant strains.
Isoform ratios for all 352 alternative splicing events included in the
microarray were used to cluster the different mutant strains.
Nucleic AcidsResearch, 2011, Vol.39,No. 2 669predictions for many events, but found also other regula-
tors that were not predicted by the microarray. We also
found that several of these alternative splicing events
which the array data suggested were regulated by
multiple factors could not be validated. In these cases it
was due to one of the alternative isoforms representing
<5% of the ﬁnal transcript; this led to a technical limita-
tion in measuring reproducible changes of these low abun-
dance minor isoforms by semi-quantitative RT–PCR.
In the analysis of the effects of mutations of different
factors on substrates, certain themes emerge. For example,
sup-12 and hrpf-1 have antagonistic effects on exon inclu-
sion for both F42G9.6 and pqn-52 indicating that their
activities counterbalance each other on these substrates
(Figure 2A and B). rsp-2 and rsp-5 mutants have
opposite effects on exon inclusion for F42G9.6, but
similar effects on exon inclusion for C06A6.4 (Figure 2A
and C). The lec-3 gene contains two alternative cassette
exons, and mutation of the neural-speciﬁc factor exc-7
leads to a 2-fold increase in use of the downstream
cassette exon and a 2-fold increase in the skipping
of both cassette exons (Figure 2D). unc-75 is also a
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Figure 2. RT–PCR validations of splicing changes for alternative splicing events with high co-regulation values; (A) F42G9.6, (B) pqn-52,
(C) C06A6.4, (D) lec-3 and (E) hrpf-1. An Agilent Bioanalyzer 2100 was used to quantitate the experimental results, error bars are shown repre-
senting results from at least two different RT–PCR reactions, and an electropherogram for each experiment is shown.
670 Nucleic Acids Research, 2011,Vol. 39,No. 2neural-speciﬁc RNA binding protein homologous to
mammalian CELF/BRUNO alternative splicing factors
(21). We analyzed an unc-75 mutant for changes in lec-3
splicing by RT–PCR and we found that, similar to muta-
tions in exc-7, mutations in unc-75 lead to a 2-fold increase
in inclusion of the downstream cassette exon. These
results indicate that neural-speciﬁc factors control lec-3
alternative splicing in neurons, and that these changes
are signiﬁcant enough to be detected in total worm
mRNA. The inclusion of the cassette exon of the
splicing factor hrpf-1 is itself regulated by other splicing
factors (Figure 2E). It is interesting to note that the lesion
in the hrpf-1 mutant strain is a 426-bp deletion in a region
of the gene upstream of the alternative cassette exon,
which should lead to a non-functional transcript; this
deletion also leads to constitutive inclusion of the alterna-
tive cassette exon in those transcripts. We previously
demonstrated that the skipping isoform of hrpf-1 is a sub-
strate for non-sense-mediated decay (25), so by lowering
the inclusion of the cassette exons, the mutations in asd-1,
fox-1, ptb-1, rsp-5 and rsp-6 lead to a decrease in the level
of HRPF-1. With the exception of the effect of the
deletion in hrpf-1 on its own splicing, it is important to
note that we could not identify any particular alternative
splicing isoform that is entirely dependent on the activity
of a single alternative splicing factor. This implies that
inputs from multiple factors contribute to alternative
splicing decisions, but that no individual decision that
we assayed for is completely dependent on a single
speciﬁc factor.
Changes in splicing factor activities during development
Several of the alternative splicing factors mutants that
have been studied in C. elegans have been reported to
show phenotypes speciﬁcally in adult worms (25,31,
33,34). These splicing factors may also have a role in em-
bryonic splicing that is without an obvious phenotype.
To study their function in more detail we performed
microarray experiments with adult mRNA for
sup-12(st89) and mec-8(e398) mutant strains. MEC-8 is
important for mechanosensory behavior in adult worms,
and SUP-12 is a known muscle-speciﬁc splicing factor
(26,31). We found examples of genes whose embryonic
alternative splicing is different between the sup-12
mutant strain and wild-type but whose splicing is identical
between these same strains in adults (i.e. F42G9.6 and
pqn-52). Table 3 summarizes the results from the
analysis of the effects of sup-12 and mec-8 both in
embryo and adult samples (Supplementary Table S2
shows the isoform ratios of each gene tested on the micro-
array for each of the mutant strains). Surprisingly, there is
no overlap between the top-scoring embryo and adult
targets for mec-8 and sup-12. We performed quantitative
RT–PCR to detect the changes in expression levels
of mec-8 and sup-12 between embryos and adults
(Figure 4). The changes in mec-8 (log2= 5.1) and
sup-12 (log2= 6.2) expression during development
detected by qRT–PCR together with previous reports
(20,31), let us conclude that both mec-8 and sup-12
change from broad expression in embryonic cells to
tissue-speciﬁc expression in adult worms. This result
suggests that developmental regulation of the transcrip-
tion of target pre-mRNAs for these splicing factors, or
changes in the relative number of cells in which the
splicing factors are expressed, may lead to changes in de-
tection of splicing targets. Alternatively, other factors that
work in combinatorial coordination with these factors to
regulate splicing may undergo changes in development
that affect the outcome.
This change of targets for splicing regulation by speciﬁc
factors during development prompted us to look at
speciﬁc targets and ask whether there are changes in the
factors that regulate their splicing during development.
We measured the adult splicing regulation for F42G9.6
and C06A6.4, two genes with high co-regulation values
in embryos as seen in Table 2. We performed RT–PCRs
on mRNA samples from adult worms for these genes from
wild-type N2 as well as asd-1, rsp-2 and rsp-5 mutant
strains. The isoform proportions for these two genes in
wild-type strains change during development (Figure 3).
Several splicing factors that have an important role in the
splicing regulation in the embryonic stage, lose this regu-
lation in the adult stage. For example, rsp-5 mutants have
a dramatic effect on C06A6.4 splicing in embryos but no
Table 3. Developmental changes in splicing regulation in mec-8(e398)
and sup-12(st89) mutant strains
Embryos Adults
Gene Exon mec-8 mec-8
Genes with high embryo regulation in mec-8
rnp-6 6 1.5 0.91
ZK1127.9 2 1.8 0.64
Y55F3AM.3 3 2.1 0.35
lin-10 6 1.5 0.02
lat-1 3 1.9  0.44
dct-17 11 1.7 0.00
unc-53 17  2.2 0.32
sox-2 2  1.8 0.32
F55C12.1 2  1.7  0.46
nlp-18 2  1.6 0.25
Genes with high embryo regulation in sup-12
F42G9.6 7  2.3  0.04
phy-2 10  1.6  0.03
gsy-1 5  1.6  0.26
Genes with high adult regulation in mec-8
unc-43 10  0.3 2.52
ccch-1 3 0.3 2.35
pqn-70 3  0.3 2.16
ret-1 7  0.1 2.04
gsy-1 5 0.9 2.02
clp-1 4  0.1 1.67
Y97E10AR.2 3 0.2 1.56
nhx-5 17  1.0  1.52
unc-2 18 0.7  1.57
ketn-1 16 0.1  1.62
gip-1 6 0.1  1.76
F28E10.1 8 0.7  1.98
hrpf-1 5 0.4  2.51
unc-89 19 0.1  2.76
Splicing events with an isoform ratio 1.5 (log2) in at least one of the
two stages (embryo or adults) for either mec-8 or sup-12. Note that for
the sup-12 mutant strain adult RNA we could detect no isoform ratios
>1.5 compared to N2 adults.
Nucleic AcidsResearch, 2011, Vol.39,No. 2 671effect on the splicing of this gene in adults (Figure 3A).
Unexpectedly we identiﬁed a splicing factor that changes
its role on a speciﬁc substrate from an enhancer in
embryos to a repressor in adults. In the rsp-5 mutant
strain there is a 2-fold decrease in F42G9.6 exon inclusion
in embryos but this same strain shows a 1.7-fold increase
in inclusion of this exon in adults. While there have been
factors shown to act as a repressor or an enhancer of
splicing on different substrates, to our knowledge this is
the ﬁrst example of an alternative splicing factor that acts
as either a repressor or an enhancer of the same splicing
event depending on the state of development. Expression
levels of these splicing factors rule out that this change in
splicing regulation could be due to the absence of rsp-5 in
adult tissues (Figure 4). We detected by quantitative
RT–PCR the levels of expression for asd-1, rsp-2 and
rsp-5 and found that while asd-1 and rsp-2 have changes
in expression between embryos and adults, log2 of  3.6
and  3.1 respectively, when compared to reference house-
keeping genes, rsp-5 maintains similar levels of expression
(log2= 0.6). This together with previous reports that
shows that rsp-5 is ubiquitously present in all nuclei of
somatic cells of adult worms (35), shows that rsp-5 is a
constitutively expressed splicing factor.
DISCUSSION
In this study, we report the splicing changes for 352 alter-
native cassette exons that occur in strains carrying 12 dif-
ferent viable mutations in alternative splicing factors.
These viable mutants represent close to 10% of the 151
RNA Recognition Motif (RRM) containing genes in
C. elegans (36). Close to 40% of the alternative cassette
exons studied have splicing changes >2-fold in the
presence of at least one of the viable mutations. One
should keep in mind that we are measuring splicing
changes in RNA extracted from whole worms, yet
several of the alternative splicing factors whose mutants
we studied are expressed in only a subset of tissues.
Therefore, it is possible that many more of the events
that were unchanged in our study are indeed regulated
by the splicing factors targeted, but that the changes in
splicing are happening in just a few cells so when we
extract RNAs from whole worms these changes are
masked by the transcripts present in other tissues. For
example, exc-7 is only expressed in neurons, and in this
study we were only able to identify one substrate, lec-3,
whose splicing is regulated by exc-7. This number of exc-7
substrates would likely increase if we were to perform the
microarray analysis with mRNA isolated speciﬁcally from
neurons. Therefore, the number of splicing targets for any
given factor in this study represents a minimum estimate.
As data is not available for many of the mutant strains as
to the number of times the alleles were outcrossed back to
N2 wild-type, it is formally possible that some of the
changes in alternative splicing we observe in the different
strains may derive from mutations in the strains that are
harbored outside of the splicing factor. However, the fox-1
mutant strain that showed the highest number of splicing
changes in embryos (Table 1) has been outcrossed back to
N2 less than ﬁve times. This is consistent with all those
changes in splicing being due to the fox-1 mutation.
In addition, we did not observe differentially-sized RT–
PCR products in our validations, consistent with a lack of
new cis-mutations in those targets. There is still a possi-
bility that a small number of changes in Table 1 may
derive from additional mutations in these strains outside
of the documented splicing factor alleles, however our
results indicate if these exist they would at best account
for only a very small fraction of the changes we observe.
One advantage of this study is that it allowed us to
identify and conﬁrm several new examples of coordinated
regulation of alternative splicing by multiple splicing
factors (Table 2, Figures 2 and 3). Combinatorial
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Figure 3. Developmental changes in splicing regulation. RT–PCRs
with embryo and adult samples were performed for C06A6.4 (A) and
F42G9.6 (B) using mRNA samples from splicing factor mutant strains
identiﬁed as regulators of embryonic splicing.
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Figure 4. Developmental changes in expression levels for splicing
factors. Detection by quantitative RT–PCR of expression changes
during development for ﬁve splicing factors. Housekeeping genes
gpd-2 and rps-1 levels were used to normalize RNA levels between
embryos and adults, and the log2 ratio of the comparison for each
factor is displayed.
672 Nucleic Acids Research, 2011,Vol. 39,No. 2regulation of alternative splicing has been identiﬁed in
several systems using biochemical and genetic approaches
(14,18,37,38). Previous work on the combinatorial regula-
tion of hnRNP A/B proteins on splicing patterns con-
cluded that each splicing factor studied has speciﬁc
afﬁnities for overlapping populations of transcripts (14).
The assembly of multiple factors onto the introns and
exons of an alternative cassette exon must allow for
control of the eventual recruitment of the splicing machin-
ery to that cassette exon. However, very little is under-
stood about the interactions between the primary
RNA-binding alternative splicing factors and the
spliceosome. Identifying multiple examples of combina-
torial alternative splicing regulation will help in establish-
ing models for the interactions that lead to splicing
decisions.
An unexpected result was the ﬁnding that the loss of
a particular splicing factor has different effects on the
splicing of the same substrate at different stages of devel-
opment (Figure 3). We found evidence that some factors
act to regulate splicing at one stage but not another. This
might be due to the factor and the substrate pre-mRNA
being expressed in the same cells at one stage of develop-
ment but not at another. One unexpected result was the
observation that mutation of the SR protein rsp-5, one
of two C. elegans homologs of the mammalian splicing
factor SC35, leads to opposite effects on splicing of the
same substrate at different stages of development. It is an
enhancer of F49G2.6 alternative cassette exon usage in
embryos and a silencer of the splicing of the same exon
in adults. This points to the possibility that rsp-5 alterna-
tive splicing activity is modulated by additional, still un-
identiﬁed regulators that are present in one developmental
stage but not the other. This possibility is further sup-
ported by the constant expression levels of rsp-5 during
development as shown by the qRT–PCR experiments
in Figure 4. That we can detect a constitutive splicing
factor with important yet different effects on the splicing
regulation of a speciﬁc substrate at different stages of de-
velopment argues that the developmental regulation is
modulated by stage-speciﬁc splicing factors that cooperate
with rsp-5 to regulate splicing.
Functional redundancy on speciﬁc substrates by
members of splicing factor families has been shown to
occur both in vitro and in vivo, and in these cases it is
important to target multiple family members in order to
see a phenotype (18,32). We observed this phenomenon by
targeting two different hnRNP F/H family members in a
double-mutant strain (Table 1). This double-mutant strain
remained viable, but this may be due to additional func-
tional redundancy with a third hnRNP F/H family
member in C. elegans, hrpf-2. The double mutant strain
allowed us to uncover many more affected substrates than
mutation of either family member alone. The logical next
step for the current work is the study at a global level of
the effects on particular alternative splicing events of the
targeting of several splicing factors at the same time. As
long as these strains are viable, this should aid in the dis-
covery of new networks of regulation that are not detect-
able when just one factor at a time is mutated. Our results
argue the importance of studying the combinatorial effect
of multiple factors on speciﬁc splicing events in order to
provide more information for the deconvolution of the
splicing code.
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